Literature DB >> 10471387

Nuclear membrane sphingomyelin-cholesterol changes in rat liver after hepatectomy.

E Albi1, I Peloso, M V Magni.   

Abstract

Sphingomyelin and cholesterol play an important role in stabilising the plasma membranes architecture and in many physiological process such as cell growth and differentiation. Degradation of sphingomyelin by exogenous sphingomyelinase induces a decrease of cholesterol due either to an increase of esterification or to a reduced biosynthesis. Variations of sphingomyelin due to the presence of a neutral-sphingomyelinase and of sphingomyelin-synthase have been recently shown in rat liver nuclear membranes. The aim of this research is to study the relation between sphingomyelin and cholesterol in the nuclear membranes following sphingomyelinase activation and during cell proliferation. The nuclear membranes, isolated from liver nuclei, were analysed for their content in protein, nucleic acids, and lipids (sphingomyelin and cholesterol) before and after sphingomyelinase activation and during hepatic regeneration. The activities of nuclear membrane SM-syntase and sphingomyelinase were also determined. The results confirmed that also in the nuclear membranes sphingomyelinase, especially exogenous, causes a strong decrease in cholesterol. The increase observed of sphingomyelin during the first 18 h after hepatectomy followed by a decrease at 24 h, due to the different activity of the enzymes, is accompanied by similar behaviour of cholesterol. This confirms the effect of neutral-sphingomyelinase on cholesterol, due to an increase of esterification process. Changes in cholesterol content modify the nuclear membranes fluidity and, as consequence, mRNA transport as previously shown. It can therefore be concluded that the neutral sphingomyelinase, present in the nuclei, may, across this mechanism, regulate the cell function. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471387     DOI: 10.1006/bbrc.1999.1188

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  High fat diet induces ceramide and sphingomyelin formation in rat's liver nuclei.

Authors:  Grzegorz Chocian; Adrian Chabowski; Małgorzata Zendzian-Piotrowska; Ewa Harasim; Bartłomiej Łukaszuk; Jan Górski
Journal:  Mol Cell Biochem       Date:  2010-02-20       Impact factor: 3.396

Review 2.  Nuclear Lipids in the Nervous System: What they do in Health and Disease.

Authors:  Mercedes Garcia-Gil; Elisabetta Albi
Journal:  Neurochem Res       Date:  2016-10-20       Impact factor: 3.996

3.  Incorporation and distribution of saturated and unsaturated fatty acids into nuclear lipids of hepatic cells.

Authors:  A Ves-Losada; S M Maté; R R Brenner
Journal:  Lipids       Date:  2001-03       Impact factor: 1.880

Review 4.  Hypercholesterolemia in Cancer and in Anorexia Nervosa: A Hypothesis for a Crosstalk.

Authors:  Giulia Gizzi; Samuela Cataldi; Claudia Mazzeschi; Elisa Delvecchio; Maria Rachele Ceccarini; Michela Codini; Elisabetta Albi
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

5.  Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.

Authors:  Zhiqiang Li; Tiruneh K Hailemariam; Hongwen Zhou; Yan Li; Dale C Duckworth; David A Peake; Youyan Zhang; Ming-Shang Kuo; Guoqing Cao; Xian-Cheng Jiang
Journal:  Biochim Biophys Acta       Date:  2007-06-06

6.  Very-long-chain fatty acid sphingomyelin in nuclear lipid microdomains of hepatocytes and hepatoma cells: can the exchange from C24:0 to C16:0 affect signal proteins and vitamin D receptor?

Authors:  Andrea Lazzarini; Antonio Macchiarulo; Alessandro Floridi; Alice Coletti; Samuela Cataldi; Michela Codini; Remo Lazzarini; Elisa Bartoccini; Giacomo Cascianelli; Francesco Saverio Ambesi-Impiombato; Tommaso Beccari; Francesco Curcio; Elisabetta Albi
Journal:  Mol Biol Cell       Date:  2015-07-01       Impact factor: 4.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.